An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Aclidinium Bromide (Tudorza Genuair): Long-term Maintenance Bronchodilator Treatment in Patients with Chronic Obstructive Pulmonary Disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug.
Top results in this bookTable of Contents
Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector.
Institute of Medicine (US) Committee to Study Medication Development and Research at the National Institute on Drug Abuse; Fulco CE, Liverman CT, Earley LE, editors.
Washington (DC): National Academies Press (US); 1995.
Clinical Review Report: Ertugliflozin (Steglatro): (Merck Canada Inc.): Indication: Type 2 Diabetes Mellitus [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Feb.
Common Drug Review New Combination Product: Ertugliflozin/Metformin Fixed-Dose Combination (Segluromet): Merck Canada Inc. Indication: Type 2 Diabetes Mellitus [Internet].
Assessment of Two Cost-Effectiveness Studies on Cocaine Control Policy.
National Research Council (US) Committee on Data and Research for Policy on Illegal Drugs; Manski CF, Pepper JV, Thomas YF, editors.
Washington (DC): National Academies Press (US); 1999.
Pharmacoeconomic Review Report: tiotropium bromide monohydrate (Spiriva Respimat) for inhalation [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Jul.
Pharmacoeconomic Review Report: Ertugliflozin (Steglatro): (Merck Canada Inc.): Indication: Type 2 Diabetes Mellitus [Internet].
Long-term Use of Ondansetron, Dolasetron and Granisetron for the Prevention of Nausea and Vomiting: A Review of the Clinical Effectiveness and Safety [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Apr 23.
CDEC Final Recommendation: Tiotropium Bromide: (Spiriva Respimat — Boehringer Ingelheim Canada Ltd.): Indication: Chronic Obstructive Pulmonary Disease [Internet].
CADTH Canadian Drug Expert Committee Final Recommendation: Tiotropium/Olodaterol: (Inspiolto Respimat – Boehringer Ingelheim Canada Ltd.): Indication: Chronic Obstructive Pulmonary Disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Dec.
CADTH Canadian Drug Expert Committee Recommendation: Ertugliflozin (Steglatro — Merck Canada Inc.): Indication: Diabetes mellitus, type 2 [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jan 25.
CADTH Canadian Drug Expert Committee Recommendation: Ertugliflozin/Metformin (Segluromet — Merck Canada Inc.): Indication: Diabetes mellitus, type 2 [Internet].
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on